Health Care & Life Sciences » Pharmaceuticals | Northeast Tiger Pharmaceutical Co. Ltd.

Northeast Tiger Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6.30
36.50
2.50
34,445.00
19,694.70
37,813.70
Cost of Goods Sold (COGS) incl. D&A
6,634.10
2,831.70
2,841.90
23,683.80
18,699.60
34,924.80
Gross Income
6,627.80
2,795.20
2,839.50
10,761.10
995.10
2,888.90
SG&A Expense
2,621.90
8,286.20
4,676.10
17,245.90
110,463.40
30,641.80
EBIT
9,249.70
11,081.40
7,515.60
6,484.70
109,468.30
27,752.90
Unusual Expense
5,667.60
25,791.00
9,584.10
278.10
2,065.20
106,258.50
Non Operating Income/Expense
13,981.10
1,264.80
2,315.20
2,044.70
728.80
561.40
Interest Expense
1,999.80
1,729.20
1,355.60
939.40
721.80
582.80
Pretax Income
8,401.80
33,612.80
8,758.90
150.70
101,955.90
135,153.30
Consolidated Net Income
8,401.80
33,612.80
8,758.90
150.70
101,955.90
136,112.70
Net Income
8,401.80
33,612.80
8,758.90
297.90
84,862.60
136,690.70
Net Income After Extraordinaries
8,401.80
33,612.80
8,758.90
297.90
84,862.60
136,690.70
Net Income Available to Common
8,401.80
33,612.80
8,758.90
297.90
84,862.60
136,690.70
EPS (Basic)
-
0.05
0.01
0.00
0.10
0.16
Basic Shares Outstanding
746,654.20
746,654.20
746,654.20
768,059.20
858,054.20
858,054.20
EPS (Diluted)
0.01
0.05
0.01
0.00
0.10
0.16
Diluted Shares Outstanding
746,654.20
746,654.20
746,654.20
768,059.20
858,054.20
858,054.20
EBITDA
2,620.60
8,282.40
4,674.90
3,368.60
107,247.50
26,825.50
Non-Operating Interest Income
2.50
3,724.00
5,730.80
5,252.00
5,440.30
2.40
Minority Interest Expense
-
-
-
147.20
17,093.40
578

About Northeast Tiger Pharmaceutical Co.

View Profile
Address
255-257 Des Voeux Road Central
Hong Kong
Hong Kong
Employees -
Website http://www.northeasttiger.com
Updated 07/08/2019
Baytacare Pharmaceutical Co. Ltd. engages in the development, manufacture, and sale of medicines. It operates through the following segments: Medicine Business, Chinese Herbs Business, Trading Business, and Big Data Business. The Medicine Business segment develops, manufactures, and sells medicines.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.